Q85.00
Neurofibromatosis, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Neurofibromatosis, unspecified (Q85.00), is a genetic disorder that causes tumors to form on nerve tissue throughout the body. These growths, called neurofibromas, are usually benign but can sometimes lead to complications depending on their size and location. The term 'unspecified' indicates that the particular type of neurofibromatosis has not been specifically classified into known subtypes, such as Type 1 (NF1) or Type 2 (NF2). This condition varies widely among individuals, with some experiencing minimal symptoms and others facing significant medical challenges.
Causes & Symptoms
Clinical Causes: Genetic mutations inherited from parents De novo mutations occurring spontaneously Mutations affecting the NF1 or NF2 genes, if specified No clear environmental cause identified
Key Symptoms: Multiple café-au-lait spots (light brown skin patches) Freckling in the underarm or groin areas Soft, benign tumors called neurofibromas under or on the skin Lisch nodules (tiny bumps on the iris of the eye) Skeletal abnormalities such as scoliosis Learning disabilities or delayed development in some cases Vision problems if tumors develop near the eyes Other neurological symptoms depending on tumor locations
Diagnostic & Treatment
Diagnosis Path: Diagnosis often involves a combination of clinical evaluation and medical history assessment. Healthcare providers may look for characteristic signs like café-au-lait spots and neurofibromas. Additional tests may include:
Treatment Protocols: While there is no cure for neurofibromatosis, treatment focuses on managing symptoms and complications. Strategies include:
Clinical Advice & FAQs
Billing Guidance
Is Q85.00 a billable ICD-10 code?
Yes, Q85.00 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q85.00?
Clinical documentation must specify the nature of Neurofibromatosis, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference